News FDA reviewers slam PTC's Duchenne drug ahead of meeting FDA staff not persuaded by patchy clinical trial evidence for Translarna.
News Bungled Brexit move would trigger public health crisis, warn... Regulator could be crippled by staff exodus during relocation.
News Public trusts supermarkets more than pharma - poll Swiss company looks move on from Tamiflu scandal
Brexit Pharma and biotech warn of Brexit threat to science recruitm... Government must strike science R&D deal with EU, says ABPI
Events Partner Content Clinical Trial Supply Midwest 2017 Leading clinical trial supply event in Chicago
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
